BOM:500660 Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 8.05B INR in the quarter ending June 30, 2025, a decrease of -1.16%. This brings the company's revenue in the last twelve months to 37.40B, up 6.65% year-over-year. In the fiscal year ending March 31, 2025, GlaxoSmithKline Pharmaceuticals had annual revenue of 37.49B with 8.56% growth.

Revenue (ttm)

37.40B

Revenue Growth

+6.65%

P/S Ratio

12.54

Revenue / Employee

12.01M

Employees

3,113

Market Cap

469.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	37.49B	2.96B	8.56%
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%
Mar 31, 2021	29.26B	-2.99B	-9.27%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reliance Industries	9,765.41B
HDFC Bank	2,736.06B
Bharti Airtel	1,839.41B
Tata Consultancy Services	2,561.48B
ICICI Bank	2,054.85B
State Bank of India	3,503.84B
Infosys	1,672.76B
Hindustan Unilever	639.28B

Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

3 months ago - Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results - Business Upturn
6 months ago - GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ... - GuruFocus
6 months ago - Q3 2025 GlaxoSmithKline Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
10 months ago - GSK Pharma sets record date for Rs 12 special interim dividend on November 7, 2024 - Business Upturn

More News